• 22 June, 2025

Merck Serono to invest $130+ million in biosimilars

September 25, 2014 | Thursday | News | By BioSpectrum Bureau

Merck Serono to invest $130+ million in biosimilars

(Photo Courtesy: www.jpifcl.com)

(Photo Courtesy: www.jpifcl.com)

Hinging on the results of its Phase I studies, Merck Serono plans to invest more than $130 million in biosimilars in 2015.

This is in addition to its previous investment in biosimilar worth €100 million this year.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s Integrated DigiTech targeting Affordable Healthcare Access?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy